Impact of microbiology cascade reporting on antibiotic de-escalation in cefazolin-susceptible Gram-negative bacteremia

[1]  J. Al-Tawfiq,et al.  Restrictive reporting of selected antimicrobial susceptibilities influences clinical prescribing. , 2015, Journal of infection and public health.

[2]  J. Garnacho-Montero,et al.  De-escalation of empirical therapy is associated with lower mortality in patients with severe sepsis and septic shock , 2013, Intensive Care Medicine.

[3]  C. Pradier,et al.  Selective reporting of antibiotic susceptibility data improves the appropriateness of intended antibiotic prescriptions in urinary tract infections: a case-vignette randomised study , 2012, European Journal of Clinical Microbiology & Infectious Diseases.

[4]  C. Mcnulty,et al.  Does laboratory antibiotic susceptibility reporting influence primary care prescribing in urinary tract infection and other infections? , 2011, The Journal of antimicrobial chemotherapy.

[5]  Lennart Sjöberg,et al.  Ahlstrand E , Persson L , Tidefelt U , Söderquist B. Alteration of the colonization pattern of coagulase-negative staphylococci in patients undergoing treatment for hematological malignancy. Eur J Clin Microbiol Infect Dis , 2011 .

[6]  J. Bartlett,et al.  Bad bugs, no drugs: no ESKAPE! An update from the Infectious Diseases Society of America. , 2009, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[7]  P. Wayne.  PERFORMANCE STANDARDS FOR ANTIMICROBIAL SUSCEPTIBILITY TESTING, NINTH INFORMATIONAL SUPPLEMENT , 2008 .

[8]  J. Burke,et al.  Infectious Diseases Society of America and the Society for Healthcare Epidemiology of America guidelines for developing an institutional program to enhance antimicrobial stewardship. , 2007, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[9]  C. Mcnulty,et al.  Laboratory antibiotic susceptibility reporting and antibiotic prescribing in general practice. , 2003, The Journal of antimicrobial chemotherapy.

[10]  R. Cunney,et al.  Interpretative reporting and selective antimicrobial susceptibility release in non-critical microbiology results. , 2000, The Journal of antimicrobial chemotherapy.

[11]  R. Morrell,et al.  Clinical use of rifampicin during routine reporting of rifampicin susceptibilities: a lesson in selective reporting of antimicrobial susceptibility data. , 1997, The Journal of antimicrobial chemotherapy.

[12]  B. Guglielmo,et al.  Experience with selective reporting of susceptibility to antimicrobial agents. , 1989, American journal of hospital pharmacy.